ClinicalTrials.govpublic full text
Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation
recurrent liver cancer after liver transplantation, atezolizumab, bevacizumab, hepatic arterial infusion chemotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 829131
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.